{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T15:40:21Z","timestamp":1740325221970,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,23]]},"DOI":"10.7759\/cureus.79501","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T15:26:41Z","timestamp":1740324401000},"source":"Crossref","is-referenced-by-count":0,"title":["Implications of Non-compliance in the Management of Chronic Polycystic Ovarian Syndrome"],"prefix":"10.7759","author":[{"given":"Avarie","family":"Willette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Nicely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Cazes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2023-000548","article-title":"Polycystic ovary syndrome: pathophysiology and therapeutic opportunities","volume":"2","author":"Dong J","year":"2023","unstructured":"Dong J, Rees DA. Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. BMJ Med. 2023, 2:e000548. 10.1136\/bmjmed-2023-000548","journal-title":"BMJ Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh037","article-title":"Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices","volume":"19","author":"Prefumo F","year":"2004","unstructured":"Prefumo F, Sebire NJ, Thilaganathan B. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum Reprod. 2004, 19:206-9. 10.1093\/humrep\/deh037","journal-title":"Hum Reprod"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092700","article-title":"The prevalence and impact of polycystic ovary syndrome in recurrent miscarriage: a retrospective cohort study and meta-analysis","volume":"9","author":"Mayrhofer D","year":"2020","unstructured":"Mayrhofer D, Hager M, Walch K, et al.. The prevalence and impact of polycystic ovary syndrome in recurrent miscarriage: a retrospective cohort study and meta-analysis. J Clin Med. 2020, 9:2700. 10.3390\/jcm9092700","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-011-0130-0","article-title":"Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease","volume":"13","author":"McGowan MP","year":"2011","unstructured":"McGowan MP. Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease. Curr Treat Options Cardiovasc Med. 2011, 13:289-301. 10.1007\/s11936-011-0130-0","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16205","article-title":"The role of androgen and its related signals in PCOS","volume":"25","author":"Ye W","year":"2021","unstructured":"Ye W, Xie T, Song Y, Zhou L. The role of androgen and its related signals in PCOS. J Cell Mol Med. 2021, 25:1825-37. 10.1111\/jcmm.16205","journal-title":"J Cell Mol Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif A","year":"1989","unstructured":"Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989, 38:1165-74. 10.2337\/diab.38.9.1165","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham AE","year":"2015","unstructured":"Joham AE, Boyle JA, Zoungas S, Teede HJ. Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity. Am J Hypertens. 2015, 28:847-51. 10.1093\/ajh\/hpu251","journal-title":"Am J Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2008.14.6.553","article-title":"Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed","volume":"14","author":"Kennedy J","year":"2008","unstructured":"Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008, 14:553-60. 10.18553\/jmcp.2008.14.6.553","journal-title":"J Manag Care Pharm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory J","year":"2019","unstructured":"Flory J, Lipska K. Metformin in 2019. JAMA. 2019, 321:1926-7. 10.1001\/jama.2019.3805","journal-title":"JAMA"},{"key":"ref10","article-title":"A logistic regression analysis of factors related to the treatment compliance of infertile patients with polycystic ovary syndrome","volume":"56","author":"Li S","year":"2011","unstructured":"Li S, He A, Yang J,  Yin T, & Xu W. A logistic regression analysis of factors related to the treatment compliance of infertile patients with polycystic ovary syndrome. The Journal of Reproductive Medicine. 2011, 56:325-32.","journal-title":"The Journal of Reproductive Medicine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228586","article-title":"Adherence to treatment for polycystic ovarian syndrome: a systematic review","volume":"15","author":"Parker M","year":"2020","unstructured":"Parker M, Warren A, Nair S, Barnard M. Adherence to treatment for polycystic ovarian syndrome: a systematic review. PLoS One. 2020, 15:e0228586. 10.1371\/journal.pone.0228586","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338275-implications-of-non-compliance-in-the-management-of-chronic-polycystic-ovarian-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T15:26:43Z","timestamp":1740324403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338275-implications-of-non-compliance-in-the-management-of-chronic-polycystic-ovarian-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.79501","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,23]]}}}